Industry Events
EnglishFrançaisEspañol中文العربية
EventosNoticiasAnálisisOrganizadores
Servicios
  • Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
  • Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
  • Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.
Suscribirse
Acceso PonentesPublicar su evento gratis
Industry Events

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

  • Industry Events
  • Noticias
  • Organizadores de eventos
  • Acerca de nosotros
  • Nuestros servicios
  • Organizador Premium
  • Event Pro
  • Conviértete en Ponente
  • Suscribirse
  • Términos
  • Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF96.7.
  • Eventos
  • Noticias
  • Análisis
  • Cuenta
Industry Events
EnglishFrançaisEspañol中文العربية
EventosNoticiasAnálisisOrganizadores
Servicios
  • Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
  • Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
  • Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.
Suscribirse
Acceso PonentesPublicar su evento gratis
Industry Events

News

Categories

  • Últimas
  • Agricultura
  • Cadena de Suministro
  • China y BRICS+
  • Ciberseguridad
  • Defensa
  • Energía y Movilidad
  • Fintech
  • IA y Tecnología
  • Robótica
  • Salud
  • Semiconductores
  • Startups y Capital Riesgo

Select a category to explore the latest industry reporting.

NewsWednesday, 26 August 2026
Newsletter subscribe · Free
  • Últimas
  • IA y Tecnología
  • Ciberseguridad
  • Semiconductores
  • Robótica
  • Fintech
  • Energía y Movilidad
  • Defensa
  • Salud
  • Cadena de Suministro
  • Startups y Capital Riesgo
  • China y BRICS+
  • Agricultura

Noticias

Salud

Las últimas noticias, anuncios y análisis del sector Salud, provenientes de las conferencias, exposiciones y cumbres que dan forma al sector.

Últimas noticias de la sección

Luigi Mangione pleads guilty to federal stalking charges in the killing of UnitedHealthcare CEO (opens original source in a new tab)
STAT News
Industry Events

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

Luigi Mangione pleads guilty to federal stalking charges in the killing of UnitedHealthcare CEO

In pleading guilty, Mangione admitted to following UnitedHealth executive Brian Thompson and then shooting him.

(opens original source in a new tab)
Associated Press·14 August 2026
STAT+: Up and down the ladder: The latest comings and goings (opens original source in a new tab)
STAT News

STAT+: Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

(opens original source in a new tab)
Ed Silverman·14 August 2026
STAT+: PBMs agree to display TrumpRx drug prices (opens original source in a new tab)
STAT News

STAT+: PBMs agree to display TrumpRx drug prices

Bristol's Zenbexus wins accelerated approval, Novartis wins UK patent fight over Entresto, and more biotech news from The Readout

(opens original source in a new tab)
Meghana Keshavan·14 August 2026
STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more (opens original source in a new tab)
STAT News

STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more

The FDA approved a Bristol oral treatment for advanced multiple myeloma, marking the debut of a new class of medicine for the blood cancer

(opens original source in a new tab)
Ed Silverman·14 August 2026
STAT+: Drug-testing lab that has sparked controversy sues group that develops drug standards over criticism (opens original source in a new tab)
STAT News

STAT+: Drug-testing lab that has sparked controversy sues group that develops drug standards over criticism

A lab that tussled with regulators over impurities found in widely used medicines has accused U.S. Pharmacopeia of making false and misleading remarks about its methods.

(opens original source in a new tab)
Ed Silverman·14 August 2026
STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class (opens original source in a new tab)
STAT News

STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of drugs for the blood cancer.

(opens original source in a new tab)
Adam Feuerstein·14 August 2026
How will legal challenges fare against CMS rule on gender-affirming care? (opens original source in a new tab)
STAT News

How will legal challenges fare against CMS rule on gender-affirming care?

A CMS rule finalized this week may prove more difficult to challenge than previous Trump administration actions to end transgender care for young people.

(opens original source in a new tab)
Theresa Gaffney·14 August 2026
Opinion: MAHA and insurance companies both want to treat human bodies like cars (opens original source in a new tab)
STAT News

Opinion: MAHA and insurance companies both want to treat human bodies like cars

“If the short history of telematics in the auto insurance taught us anything, it’s to be skeptical of any promises attached to shareable surveillance data.”

(opens original source in a new tab)
Andréa Becker and Paul Kamuf·14 August 2026
STAT+: Commure terminates payments under its customer referral programs tied to AI products (opens original source in a new tab)
STAT News

STAT+: Commure terminates payments under its customer referral programs tied to AI products

Commure, which develops and sells AI products to clinics, has terminated a program that paid for referrals to new customers.

(opens original source in a new tab)
Casey Ross and Brittany Trang·13 August 2026
STAT+: Eli Lilly targets booming black market for retatrutide (opens original source in a new tab)
STAT News

STAT+: Eli Lilly targets booming black market for retatrutide

Khartis raises oral immunology funds, Neurocrine drug safety concerns, and more biotech news from The Readout

(opens original source in a new tab)
Meghana Keshavan·13 August 2026
STAT+: Kennedy heads west, slams Becerra (opens original source in a new tab)
STAT News

STAT+: Kennedy heads west, slams Becerra

The health secretary headed to California to lay out the government's new approach to addiction treatment.

(opens original source in a new tab)
John Wilkerson·13 August 2026
STAT+: Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and more (opens original source in a new tab)
STAT News

STAT+: Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and more

Seven months after the launch of its own low-cost insulin brand, California has distributed more than 120,000 five-pen packs of insulin glargine priced at $55 each

(opens original source in a new tab)
Ed Silverman·13 August 2026

Los más leídos

  1. 01

    Luigi Mangione pleads guilty to federal stalking charges in the killing of UnitedHealthcare CEO

  2. 02

    STAT+: Up and down the ladder: The latest comings and goings

  3. 03

    STAT+: PBMs agree to display TrumpRx drug prices

  4. 04

    STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more

  5. 05

    STAT+: Drug-testing lab that has sparked controversy sues group that develops drug standards over criticism

Prev
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
Next
  • Industry Events
  • Noticias
  • Organizadores de eventos
  • Acerca de nosotros
  • Nuestros servicios
  • Organizador Premium
  • Event Pro
  • Conviértete en Ponente
  • Suscribirse
  • Términos
  • Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF96.7.

La semana en eventos de la industria, entregada cada viernes.

Un email corto. Las mejores historias de ferias, conferencias y cumbres que dan forma a los negocios mundiales. Sin relleno, sin spam, cancela en cualquier momento.